Please use this identifier to cite or link to this item:
https://doi.org/10.1016/j.compbiomed.2013.01.015
Title: | In silico prediction of spleen tyrosine kinase inhibitors using machine learning approaches and an optimized molecular descriptor subset generated by recursive feature elimination method | Authors: | Li, B.-K. Cong, Y. Yang, X.-G. Xue, Y. Chen, Y.-Z. |
Keywords: | Machine learning methods (ML methods) Recursive feature elimination (RFE) Rheumatoid arthritis (RA) Spleen tyrosine kinase (Syk) Support vector machine (SVM) |
Issue Date: | 1-May-2013 | Citation: | Li, B.-K., Cong, Y., Yang, X.-G., Xue, Y., Chen, Y.-Z. (2013-05-01). In silico prediction of spleen tyrosine kinase inhibitors using machine learning approaches and an optimized molecular descriptor subset generated by recursive feature elimination method. Computers in Biology and Medicine 43 (4) : 395-404. ScholarBank@NUS Repository. https://doi.org/10.1016/j.compbiomed.2013.01.015 | Abstract: | We tested four machine learning methods, support vector machine (SVM), k-nearest neighbor, back-propagation neural network and C4.5 decision tree for their capability in predicting spleen tyrosine kinase (Syk) inhibitors by using 2592 compounds which are more diverse than those in other studies. The recursive feature elimination method was used for improving prediction performance and selecting molecular descriptors responsible for distinguishing Syk inhibitors and non-inhibitors. Among four machine learning models, SVM produces the best performance at 99.18% for inhibitors and 98.82% for non-inhibitors, respectively, indicating that the SVM is potentially useful for facilitating the discovery of Syk inhibitors. © 2013 Elsevier Ltd. | Source Title: | Computers in Biology and Medicine | URI: | http://scholarbank.nus.edu.sg/handle/10635/106035 | ISSN: | 00104825 | DOI: | 10.1016/j.compbiomed.2013.01.015 |
Appears in Collections: | Staff Publications |
Show full item record
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.